HDL functions and their interaction in patients with ST elevation myocardial infarction: a case control study

Relationship of High-Density Lipoprotein-Associated Arylesterase Activity to Systolic Heart Failure in Patients with and without Type 2 Diabetes

(2019) Chang Li et al.   Scientific Reports

Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes

(2018) Alena Viktorinova et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Effects of Cardiac Rehabilitation on High-Density Lipoprotein-mediated Cholesterol Efflux Capacity and Paraoxonase-1 Activity in Patients with Acute Coronary Syndrome

(2018) Fumiaki Furuyama et al.   Journal of Atherosclerosis and Thrombosis

Cardioprotective Effects of High-Density Lipoprotein Beyond its Anti-Atherogenic Action

(2018) Manabu Nagao et al.   Journal of Atherosclerosis and Thrombosis

CSL112, a reconstituted, infusible, plasma-derived apolipoprotein A-I: safety and tolerability profiles and implications for management in patients with myocardial infarction

(2018) Davide Capodanno et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Association of Serum Cholesterol Efflux Capacity With Mortality in Patients With ST-Segment Elevation Myocardial Infarction

(2018) Maryse Guerin et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial InfarctionClinical Perspective

(2016) C. Michael Gibson et al.   CIRCULATION

HDL function is impaired in acute myocardial infarction independent of plasma HDL cholesterol levels

(2016) Wijtske Annema et al.   Journal of Clinical Lipidology

Beyond Coronary Calcification, Family History, and C-Reactive Protein

(2016) Purav Mody et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study

(2015) Danish Saleheen et al.   Lancet Diabetes & Endocrinology

Beginning to Understand High-Density Lipoproteins

(2014) Carlos G. Santos-Gallego et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial

(2014) Kausik K. Ray et al.   EUROPEAN HEART JOURNAL

Mendelian randomization studies in coronary artery disease

(2014) H. Jansen et al.   EUROPEAN HEART JOURNAL

HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events

(2014) Anand Rohatgi et al.   NEW ENGLAND JOURNAL OF MEDICINE

High-Density Lipoprotein Mediated Cellular Cholesterol Efflux in Acute Coronary Syndromes

(2013) Anouar Hafiane et al.   AMERICAN JOURNAL OF CARDIOLOGY

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

(2012) Benjamin F Voight et al.   LANCET

A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterol

(2011) Sandhya Sankaranarayanan et al.   JOURNAL OF LIPID RESEARCH

Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis

(2011) Amit V. Khera et al.   NEW ENGLAND JOURNAL OF MEDICINE

Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

The Ability to Promote Efflux Via ABCA1 Determines the Capacity of Serum Specimens With Similar High-Density Lipoprotein Cholesterol to Remove Cholesterol From Macrophages

(2010) Margarita de la Llera-Moya et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Modification of High Density Lipoprotein by Myeloperoxidase Generates a Pro-inflammatory Particle

(2009) Arundhati Undurti et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Cholesteryl Ester Transfer Protein Inhibition, High-Density Lipoprotein Raising, and Progression of Coronary Atherosclerosis

(2008) Stephen J. Nicholls et al.   CIRCULATION